The data adds to the limited knowledge of incretins in the pathophysiology of human NAFLD and substantiate the hypothesis that the GLP-1/GLP-1R system is impaired. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.